Delivery Order SPE2DB22D1106-SPE2DB23FEVS0
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at seventy-four thousand sixty-one dollars and nineteen cents ($74,061.19) to Amerisourcebergen Drug Corporation for the provision of two hundred fifty (250) units of the antimalarial drug atovaquone-proguanil. Performance will occur at the prime contractor's facility located in Conshohocken, Pennsylvania under a start date of September 22, 2023 and an end date of September 25, 2023. As the Defense Logistics Agency...
- The Defense Logistics Agency awarded a $14,922.01 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets) on September 12, 2025, with a completion date of September 15, 2025. This is a firm fixed price order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a $1,426.28 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100S tablets on October 22, 2025, with completion expected by October 23, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under the company's broader relationship with DLA. The order is being fulfilled from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,100.20 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Atovaquone-Proguanil 250-100 (100 tablets). This is a firm fixed-price delivery order with no set-aside designation, demonstrating that the award was competitively procured. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $38,491.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 250-100 count packages of atovaquone-proguanil, an antimalarial medication. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania from September 22nd through September 25th, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to ensure medical supplies like...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Atovaquone-Proguanil 250-100 tablets in a quantity of 100 units, with a ceiling value of $1,343.16. This contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside transaction. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,586.54 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 tablets in a quantity of 100 units. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 11, 2025, and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The product being...
- The Defense Logistics Agency awarded a delivery order valued at $38,258.58 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets in a quantity of 100 units. This competitively awarded, firm fixed-price contract with no set-aside designation was issued on November 13, 2025, with an ultimate completion date of November 14, 2025. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,245.97 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 (100 tablets), a antimalarial medication used primarily for malaria prophylaxis and treatment in military personnel. The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,044.48 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). This firm fixed-price delivery order is non-set-aside and scheduled for ultimate completion by November 14, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The antimalarial medication will support military and federal healthcare requirements through the agency's...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB23FEVS0Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at ninety-eight thousand five hundred eighty-one dollars and eighty-six cents ($98,581.86) to Amerisourcebergen Drug Corporation for the provision of two hundred fifty (250) tablets of atovaquone-proguanil and one hundred (100) tablets of the same medication. Performance will occur at the prime contractor's facility located in Conshohocken, Pennsylvania through August eighteenth, two thousand twenty-three (August 18, 2023). No subcontractors or set aside designations were identified. The Defense Logistics Agency supports America's armed forces by providing supplies in healthcare, industrial operations, and weapon systems sustainment through contracts like this delivery order for essential malaria prophylaxis medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $98.6k | 8/17/23 |